Please login to the form below

Not currently logged in

Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences

Caulfield served as chief scientist at Genomics England, working on the 100,000 Genomes Project

Mark Caulfield (pictured above) has departed from Genomics England to take on the chief executive officer role at Barts Life Sciences – a research and innovation partnership between Queen Mary University of London and Barts Health NHS Trust.

At Genomics England, Caulfield served as chief scientist – in 2013, he took leadership of the scientific oversight and delivery of the 100,000 Genomes Project.

He was awarded a knighthood in 2019 following the project’s ‘unprecedented success’, Genomics England said in a statement.

First launched in 2012, the 100,000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer.

In 2018, Genomics England announced it had sequenced its 100,000th genome as part of the project.

At Barts Life Sciences, Caulfield will be responsible for the overall leadership and delivery of the programme and work alongside key stakeholders including Department of Health and Social Care, Office for Life Sciences, London Borough of Tower Hamlets, NHS Property Services and Barts Charity.

“I’m delighted to be joining Barts Life Sciences to lead the delivery of a thriving life sciences cluster at the heart of Whitechapel,” said Caulfield.

"By bringing together the NHS, academia, industry and health science organisations we will inspire, invent, and accelerate the adoption of cutting-edge medical innovations, that meet the needs of our local population and improve health for all,” he added.

Article by
Lucy Parsons

2nd July 2021

From: Research


COVID-19 Updates and Daily News

Featured jobs


Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...